These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23439627)

  • 1. Canada lags on transparency of industry-doctor relationships.
    Collier R
    CMAJ; 2013 Apr; 185(6):E245-6. PubMed ID: 23439627
    [No Abstract]   [Full Text] [Related]  

  • 2. The Sunshine Act--effects on physicians.
    Agrawal S; Brennan N; Budetti P
    N Engl J Med; 2013 May; 368(22):2054-7. PubMed ID: 23718163
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships with the drug industry: More regulation, greater transparency.
    Krumholz HM; Ross JS
    BMJ; 2009 Feb; 338():b211. PubMed ID: 19193612
    [No Abstract]   [Full Text] [Related]  

  • 4. Transparency and the Doctor-Patient Relationship - Rethinking Conflict-of-Interest Disclosures.
    Adashi EY; Cohen IG; Elberg JT
    N Engl J Med; 2022 Jan; 386(4):300-302. PubMed ID: 35061340
    [No Abstract]   [Full Text] [Related]  

  • 5. The Sunshine Act: it's for real now.
    Katayama AC
    WMJ; 2013 Apr; 112(2):96-7. PubMed ID: 23758019
    [No Abstract]   [Full Text] [Related]  

  • 6. The Physician Payments Sunshine Act: Implications and Predictions.
    Litman RS
    Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29363562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patient attitudes and expectations towards conflicts of interest of attending physicians].
    Riedl EM; König J; Koch C; Lieb K
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():45-53. PubMed ID: 26875035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry relationships between physicians and professional medical associations: corrupt or essential?
    Smith CD; MacFadyen B
    Surg Endosc; 2010 Feb; 24(2):251-3. PubMed ID: 20087748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to peer commentaries on "Clarifying conflict of interest".
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):W4-5. PubMed ID: 21240796
    [No Abstract]   [Full Text] [Related]  

  • 10. Nothing to hide, something to gain? how the US Sunshine Act may effect Canadian doctors.
    Rivers J
    J Cutan Med Surg; 2012; 16(3):145-8. PubMed ID: 22930849
    [No Abstract]   [Full Text] [Related]  

  • 11. Doctors and drug companies--scrutinizing influential relationships.
    Campbell EG
    N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transparency alone is not sufficient for the management of conflicts of interest - pro].
    Lieb K
    Psychiatr Prax; 2015 Jan; 42(1):12-3. PubMed ID: 25585000
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients expect transparency in doctors' relationships with the pharmaceutical industry. Comment.
    Dalton BS; Richards DJ
    Med J Aust; 2009 Apr; 190(8):460; author reply 460-1. PubMed ID: 19562859
    [No Abstract]   [Full Text] [Related]  

  • 14. Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.
    Rosenthal MB; Mello MM
    N Engl J Med; 2013 May; 368(22):2052-4. PubMed ID: 23718162
    [No Abstract]   [Full Text] [Related]  

  • 15. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Gough IR; Dickinson I; Maddern G; Grigg M; Hillis DJ
    Med J Aust; 2010 Mar; 192(5):293-4. PubMed ID: 20201768
    [No Abstract]   [Full Text] [Related]  

  • 16. Shedding light on what the Sunshine Act will mean for physicians.
    Katayama AC
    WMJ; 2012 Feb; 111(1):39-40. PubMed ID: 22533215
    [No Abstract]   [Full Text] [Related]  

  • 17. Sunshine laws and the pharmaceutical industry.
    Brennan TA; Mello MM
    JAMA; 2007 Mar; 297(11):1255-7. PubMed ID: 17374820
    [No Abstract]   [Full Text] [Related]  

  • 18. Another dip into the muddy waters of COI.
    Stell LK; Stossel TP
    Am J Bioeth; 2011 Jan; 11(1):49-50. PubMed ID: 21240813
    [No Abstract]   [Full Text] [Related]  

  • 19. US to require public disclosure of drug and device industry's financial ties to doctors.
    Epstein K
    BMJ; 2012 Jan; 344():e515. PubMed ID: 22262802
    [No Abstract]   [Full Text] [Related]  

  • 20. CMS LAUNCHES 'OPEN PAYMENTS' SITE DESPITE PHYSICIAN CONCERNS.
    Ritchie A
    Med Econ; 2014 Oct; 91(20):50. PubMed ID: 26242084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.